|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| EXPENSES | |||||
| Research and development | |||||
| Nonrelated Party | |||||
| Total research and development | |||||
| Research and development - related parties [note 11] | |||||
| General and administrative | |||||
| Nonrelated Party | |||||
| Total general and administrative | |||||
| General and administrative - related parties [note 11] | |||||
| Total operating expenses | |||||
| OTHER INCOME (EXPENSE) | |||||
| Interest income | |||||
| Interest expense [note 8] | |||||
| Change in fair value of contingent consideration [note 5 and note 6] | |||||
| Loss on extinguishment of 2023 SVB convertible term loan [note 8] | |||||
| Other income (expense) | |||||
| Total other income (expense) | |||||
| Net Loss | |||||
| OTHER COMPREHENSIVE INCOME (LOSS) | |||||
| Net unrealized gain (loss) on securities | |||||
| Total other comprehensive income (loss) | |||||
| Comprehensive loss | |||||
| Basic net loss per common share [note 10 [i]] | |||||
| Diluted net loss per common share [note 10 [i]] | |||||
| Shares used in computation of basic net loss per common share [note 10 [i]] | |||||
| Shares used in computation of Diluted net loss per common share [note 10 [i]] | |||||
Loading...